{"id":4401,"date":"2024-11-19T18:13:00","date_gmt":"2024-11-19T16:13:00","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=4401"},"modified":"2026-10-30T13:29:43","modified_gmt":"2026-10-30T11:29:43","slug":"participation-of-iasis-pharma-in-the-45th-panhellenic-congress-of-cardiology","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/participation-of-iasis-pharma-in-the-45th-panhellenic-congress-of-cardiology\/","title":{"rendered":"PARTICIPATION OF IASIS PHARMA IN THE \u201c45th PANHELLENIC CONGRESS OF CARDIOLOGY\u201d"},"content":{"rendered":"<p><strong><b>31\/10 \u2013 02\/11 2024<\/b><\/strong><\/p>\n<p><strong><b>Hersonissos, Crete<\/b><\/strong>.<\/p>\n<p><strong><b>IASIS PHARMA<\/b><\/strong>\u00a0participated in the\u00a0<strong><b>\u201c45<\/b><\/strong><strong><sup><b>th<\/b><\/sup><\/strong><strong><b>\u00a0PANHELLENIC CONGRESS OF CARDIOLOGY\u201d<\/b><\/strong>\u00a0which was held from\u00a0<strong><b>31\/10 <\/b><\/strong>to<strong><b>\u00a002\/11 2024,<\/b><\/strong>\u00a0at\u00a0the Cultural Conference Center \u201cMikis Theodorakis\u201d at <strong><b>Hersonissos\/Crete<\/b><\/strong>.<\/p>\n<p>The conference was organized by the\u00a0<strong><b>Hellenic Society of Cardiology (HSC).<\/b><\/strong><\/p>\n<p>The\u00a0<strong><b>Panhellenic Congress of Cardiology<\/b><\/strong>\u00a0has established among Cardiologists and the Pharmaceutical Industry, as the Scientific Conference par excellence, with the largest participation of renowned Greek Scientists, high level of submitted abstracts and published poster presentations.<\/p>\n<p><strong><b>IASIS PHARMA<\/b><\/strong>\u00a0presented at its exhibition stand the following products:<\/p>\n<ul>\n<li><strong>RosuZet<sup>\u00ae<\/sup><\/strong>:\u00a0<strong><b>New Product Launching<\/b><\/strong>. Fixed-dose combination of <strong><b>Rosuvastatin &amp; Ezetimibe<\/b><\/strong>, in a single dosage form, in packages of 30 f.c. tabs available in the full spectrum of strengths:\u00a05 \/ 10mg, 10 \/ 10mg, 20 \/ 10mg, 40 \/ 10mg<\/li>\n<li><strong>Rami<\/strong><strong>&#8211;<\/strong><strong>Amlo<sup>\u00ae<\/sup><\/strong>\/ Ramipril &amp; Amlodipine: the original fixed dose combination of angiotensin-converting enzyme inhibitors with calcium channel blockers. Therapeutic indication, substitution therapy in patients whose blood pressure is adequately controlled with ramipril and amlodipine simultaneously at the same dose level. (Box of 28 caps, Ramipril \/ Amlodipine: 5mg \/ 5mg, 5mg \/ 10mg, 10mg \/ 5mg, 10mg \/ 10mg).<\/li>\n<li><strong>Rami<\/strong><strong>&#8211;<\/strong><strong>Amlo\u00a0plus<sup>\u00ae\u00a0<\/sup><\/strong>the original, fixed dose combination of Ramipril \u2013 Amlodipine \u2013 Hydrochlorothiazide, indicated for the treatment of Hypertension. (Box of 30 caps, Ramipril \/ Amlodipine \/ Hydrochlorothiazide: 5 mg \/ 5 mg \/ 12,5 mg, 5 mg \/ 5 mg \/ 25 mg, 10 mg \/ 5 mg \/ 25 mg, 10 mg \/ 10 mg \/ 25 mg).<\/li>\n<li><strong>Licepler<sup>\u00ae<\/sup><\/strong>\u00a0\/ Eplerenone: Licepler is specifically indicated for the reduction of risk of cardiovascular death in people with heart failure and left ventricular dysfunction \u226440% after a recent acute myocardial infarction, in combination with standard therapies and as treatment against hypertension. (Box of 30 tabs at 25mg &amp; 50mg).<\/li>\n<li><strong>MAG<\/strong><strong>&#8211;<\/strong><strong>IASIS<sup>\u00ae\u00a0<\/sup><\/strong>\/\u00a0243 mg Magnesium, main indications: Conditions of magnesium deficiency if these cannot be treated through nutrition. Disorders of muscle function, caused by confirmed magnesium deficiency (neuromuscular disorders, muscle cramps, such as gastrocnemius cramps, nocturnal cramps). (Box of 40 eff. tabs).<\/li>\n<\/ul>\n<p><img decoding=\"async\" class=\"alignleft wp-image-4398\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2024\/11\/kardiologiko-2024-copy.png\" alt=\"\u039a\u03b1\u03c1\u03b4\u03b9\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03cc \u03a3\u03c5\u03bd\u03ad\u03b4\u03c1\u03b9\u03bf\" width=\"471\" height=\"605\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>31\/10 \u2013 02\/11 2024 Hersonissos, Crete. IASIS PHARMA\u00a0participated in the\u00a0\u201c45th\u00a0PANHELLENIC CONGRESS OF CARDIOLOGY\u201d\u00a0which was held from\u00a031\/10 to\u00a002\/11 2024,\u00a0at\u00a0the Cultural Conference Center \u201cMikis Theodorakis\u201d at Hersonissos\/Crete. The conference was organized by the\u00a0Hellenic Society of Cardiology (HSC). The\u00a0Panhellenic Congress of Cardiology\u00a0has established among Cardiologists and the Pharmaceutical Industry, as the Scientific Conference par excellence, with the largest  [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":true,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,157,204],"tags":[],"class_list":["post-4401","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-press-room-en","category-conferences"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-18Z","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=4401"}],"version-history":[{"count":3,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4401\/revisions"}],"predecessor-version":[{"id":4404,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4401\/revisions\/4404"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=4401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=4401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=4401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}